Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Nov 15;90(22):10454-8.
doi: 10.1073/pnas.90.22.10454.

A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions

Affiliations

A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions

M F Callan et al. Proc Natl Acad Sci U S A. .

Abstract

Study of the T-cell repertoire in humans has been hampered by the lack of monoclonal antibodies (mAbs) to the T-cell receptor (TCR) variable region (V) gene products. We describe a method for producing mAbs to the human TCR beta-chain V (V beta) gene products in which mice were immunized with a rat basophil cell line (RBL-2H3) transfected with the extracellular domain of the TCR heterodimer fused to the lambda chain of CD3. These cells acted as excellent immunogens for raising anti-TCR mAb and also formed the basis of a rapid screening assay. We generated mAbs against V beta protein of the TCR, showed that these mAbs stained approximately 1% of peripheral blood T cells, and further showed that the mAbs could stimulate proliferation of these T cells. We then characterized the mAbs by amplifying TCR cDNA derived from mAb-stimulated cells and sequencing the beta chain. All clones sequenced used the V beta 7.1 chain, proving conclusively that the mAbs generated were specific for V beta 7.1 subfamily. This method generates mAbs to human TCR V beta proteins efficiently and might allow production of a complete panel of mAbs directed against human TCR V beta proteins.

PubMed Disclaimer

References

    1. J Exp Med. 1993 Jun 1;177(6):1623-31 - PubMed
    1. J Exp Med. 1993 May 1;177(5):1487-92 - PubMed
    1. Eur J Immunol. 1993 Jul;23(7):1422-9 - PubMed
    1. Methods Enzymol. 1981;73(Pt B):3-46 - PubMed
    1. Eur J Immunol. 1985 Jul;15(7):738-42 - PubMed

Publication types

Substances

LinkOut - more resources